Analyst Price Target is $12.80
▲ +306.35% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Columbia Care in the last 3 months. The average price target is $12.80, with a high forecast of $19.00 and a low forecast of $5.20. The average price target represents a 306.35% upside from the last price of $3.15.
Current Consensus is
The current consensus among 6 investment analysts is to buy stock in Columbia Care.
Columbia Care, Inc. engages in the cultivation, manufacture and provision of medical cannabis products and services. It distributes its products under the EleCeed, TheraCeed, and ClaraCeed brands. The company was founded by Nicholas Vita and Michael Abbott in 2012 and is headquartered in New York, NY.